Pesquisas alternativas:
drug dosealer » drug dealer (Expandir a Pesquisa), drug disease (Expandir a Pesquisa), drug dosage (Expandir a Pesquisa)
level theory » legal theory (Expandir a Pesquisa), model theory (Expandir a Pesquisa), cell theory (Expandir a Pesquisa)
drug dosev » drug doses (Expandir a Pesquisa), drug does (Expandir a Pesquisa), drug dev (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug dosealer » drug dealer (Expandir a Pesquisa), drug disease (Expandir a Pesquisa), drug dosage (Expandir a Pesquisa)
level theory » legal theory (Expandir a Pesquisa), model theory (Expandir a Pesquisa), cell theory (Expandir a Pesquisa)
drug dosev » drug doses (Expandir a Pesquisa), drug does (Expandir a Pesquisa), drug dev (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
1
Por David C. Norris
Publicado em 2017-03-01
Assuntos:
“...Theory & Simulation...”Publicado em 2017-03-01
Obter o texto integral
Artigo
2
Por Lam, Fred C, Vu-Han, Tu-Lan, Van de Kooj, Bert, Kong, Yi Wen, Bandopadhayay, Pratiti, Beroukhim, Rameen, Sarkaria, Jann, Hammond, Paula, Yaffe, Michael
Publicado no Neuro Oncol (2019)
“... of the DNA damage response in cells that allows for the discovery of novel higher order synergistic drug...”Publicado no Neuro Oncol (2019)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Kim, Yo Han, Choi, Hee Youn, Lim, Hyeong-Seok, Lee, Shi Hyang, Jeon, Hae Sun, Hong, Donghyun, Kim, Seong Su, Choi, Young Kweon, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)
“.... The aim of this randomized, single-blind, placebo-controlled, single-dose, dose-escalation study...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... the diseased anterior ocular tissue, generate high drug levels, and maintain prolonged and effective...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“...Brivaracetam (BRV), the n-propyl analogue of levetiracetam (LEV), is the latest antiepileptic drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... levels (i.e., less than 0.01%) and by 6-aminoisoproterenol to less than 0.4%. Both polymeric...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Alhameed, Abrar F, Khansa, Sara Al, Hasan, Hani, Ismail, Sherine, Aseeri, Mohammed
Publicado no Pharmacy (Basel) (2019)
“... included assessing the mean differences in proportions of correct dose adjustments and correct drug...”Publicado no Pharmacy (Basel) (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Kim, Yo Han, Choi, Hee Youn, Lee, Shi Hyang, Lim, Hyeong-Seok, Miki, Tokutaro, Kang, Jong-Koo, Han, Kyoung-Goo, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)
“... and pharmacokinetics of HX-1171 in healthy volunteers. METHODS: A randomized, single-blind, placebo-controlled, dose...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Mirinejad, Hossein, Gaweda, Adam E., Brier, Michael E., Zurada, Jacek M., Inanc, Tamer
Publicado no Comput Methods Programs Biomed (2017)
“... dosing approach to anemia management by leveraging the theory of optimal control. METHODS: A Multiple...”Publicado no Comput Methods Programs Biomed (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Kostich, Walter, Hamman, Brian D., Li, Yu-Wen, Naidu, Sreenivasulu, Dandapani, Kumaran, Feng, Jianlin, Easton, Amy, Bourin, Clotilde, Baker, Kevin, Allen, Jason, Savelieva, Katerina, Louis, Justin V., Dokania, Manoj, Elavazhagan, Saravanan, Vattikundala, Pradeep, Sharma, Vivek, Das, Manish Lal, Shankar, Ganesh, Kumar, Anoop, Holenarsipur, Vinay K., Gulianello, Michael, Molski, Ted, Brown, Jeffrey M., Lewis, Martin, Huang, Yanling, Lu, Yifeng, Pieschl, Rick, O’Malley, Kevin, Lippy, Jonathan, Nouraldeen, Amr, Lanthorn, Thomas H., Ye, Guilan, Wilson, Alan, Balakrishnan, Anand, Denton, Rex, Grace, James E., Lentz, Kimberley A., Santone, Kenneth S., Bi, Yingzhi, Main, Alan, Swaffield, Jon, Carson, Ken, Mandlekar, Sandhya, Vikramadithyan, Reeba K., Nara, Susheel J., Dzierba, Carolyn, Bronson, Joanne, Macor, John E., Zaczek, Robert, Westphal, Ryan, Kiss, Laszlo, Bristow, Linda, Conway, Charles M., Zambrowicz, Brian, Albright, Charles F.
Publicado no J Pharmacol Exp Ther (2016)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Levant, Beth, Zarcone, Troy J., Davis, Paul F., Ozias, Marlies K., Fowler, Stephen C.
Publicado em 2011
“..., and methylphenidate increased locomotion in a dose-related manner. The introduction of a novel spatial stimulus...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Hayashi, Tomoko, Crain, Brian, Yao, Shiyin, Caneda, Christa D., Cottam, Howard B., Chan, Michael, Corr, Maripat, Carson, Dennis A.
Publicado em 2014
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Zhang, Haoming, Lauver, D. Adam, Wang, Hui, Sun, Duxin, Hollenberg, Paul F., Chen, Y. Eugene, Osawa, Yoichi, Eitzman, Daniel T.
Publicado no J Pharmacol Exp Ther (2016)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kalinichev, Mikhail, Le Poul, Emmanuel, Boléa, Christelle, Girard, Françoise, Campo, Brice, Fonsi, Massimiliano, Royer-Urios, Isabelle, Browne, Susan E., Uslaner, Jason M., Davis, Matthew J., Raber, Jacob, Duvoisin, Robert, Bate, Simon T., Reynolds, Ian J., Poli, Sonia, Celanire, Sylvain
Publicado em 2014
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“...Nonsteroidal anti-inflammatory drugs (NSAIDs) elevate cardiovascular risk by disrupting...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Sunwoo, Jung, Kim, Yu Kyong, Choi, Yewon, Yu, Kyung-Sang, Nam, Heesook, Cho, Young Lag, Yoon, Seonghae, Chung, Jae-Yong
Publicado no Drug Des Devel Ther (2018)
“...BACKGROUND: LCB01-0371 is a novel oxazolidinone antibiotic that blocks protein production...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Gu, Namyi, Park, Min Kyu, Kim, Tae-Eun, Bahng, Mi Young, Lim, Kyoung Soo, Cho, Sang-Heon, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin, Yu, Kyung-Sang
Publicado em 2014
“...PURPOSE: Evogliptin (DA-1229) is a novel, potent, and selective dipeptidyl peptidase IV (DPP-IV...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Wang, Wei-Peng, Ho, Pui Yan, Chen, Qiu-Xia, Addepalli, Balasubrahmanyam, Limbach, Patrick A., Li, Mei-Mei, Wu, Wen-Juan, Jilek, Joseph L., Qiu, Jing-Xin, Zhang, Hong-Jian, Li, Tianhong, Wun, Theodore, White, Ralph DeVere, Lam, Kit S., Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Hay, Meredith, Polt, Robin, Heien, Michael L., Vanderah, Todd W., Largent-Milnes, Tally M., Rodgers, Kathleen, Falk, Torsten, Bartlett, Mitchell J., Doyle, Kristian P., Konhilas, John P.
Publicado no J Pharmacol Exp Ther (2019)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“...A novel composite endpoint, sustained pain-free/no adverse events, was recently proposed as a more...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo